Evidence map›Paper›PMID 24189143›Full record

ArticleEndocrinology2014

Prostaglandins are essential for cervical ripening in LPS-mediated preterm birth but not term or antiprogestin-driven preterm ripening.

Brenda C Timmons, Jeff Reese, Simona Socrate, Noah Ehinger, Bibhash C Paria, Ginger L Milne, Meredith L Akins, Richard J Auchus, Don McIntire, Michael House and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Toll-like receptor 2/4 inhibitors can reduce preterm birth in mice.The Journal of international medical research · 2020
    Article
  16. Erythropoietin prevents LPS-induced preterm birth and increases offspring survival.American journal of reproductive immunology (New York, N.Y. : 1989) · 2020
    Article
  17. Review
  18. Article
  19. Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Brenda C TimmonsDepartment of Obstetrics and Gynecology and Green Center for Reproductive Biology Sciences (B.C.T., M.L.A., D.M., M.M.), University of Texas Southwestern Medical Center, Dallas, Texas 75235; Department of Pediatrics, Cell, and Developmental Biology (J.R., N.E., B.C.P.) and Eicosanoid Core Laboratory (G.L.M.), Vanderbilt University, Nashville, Tennessee 37221; Department of Mechanical Engineering (S.S.), Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307; Department of Internal Medicine (R.J.A.), University of Michigan, Ann Arbor, Michigan 48109; and Department of Obstetrics and Gynecology (M.H.), Tufts Medical Center, Boston, Massachusetts 02111.
Jeff Reese
Simona Socrate
Noah Ehinger
Bibhash C Paria
Ginger L Milne
Meredith L Akins
Richard J Auchus
Don McIntire
Michael House
Mala Mahendroo
The University of Texas Southwestern Medical Center · USVanderbilt University · USMassachusetts Institute of Technology · USTufts Medical Center · USUniversity of Michigan–Ann Arbor · US

Funding

Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kanakadurga Singer · 2010 to 2026
$20.3M
Molecular Mechanisms of ParturitionR01HD043154 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI MAHENDROO, MALA S. · 2003 to 2010
$2.1M
NICHD NIH HHS R01 HD043154NIDDK NIH HHS DK089503NIDDK NIH HHS P30 DK089503
6 · The paper itself

Abstract

Globally, an estimated 13 million preterm babies are born each year. These babies are at increased risk of infant mortality and life-long health complications. Interventions to prevent preterm birth (PTB) require an understanding of processes driving parturition. Prostaglandins (PGs) have diverse functions in parturition, including regulation of uterine contractility and tissue remodeling. Our studies on cervical remodeling in mice suggest that although local synthesis of PGs are not increased in term ripening, transcripts encoding PG-endoperoxide synthase 2 (Ptgs2) are induced in lipopolysaccharide (LPS)-mediated premature ripening. This study provides evidence for two distinct pathways of cervical ripening: one dependent on PGs derived from paracrine or endocrine sources and the other independent of PG actions. Cervical PG levels are increased in LPS-treated mice, a model of infection-mediated PTB, consistent with increases in PG synthesizing enzymes and reduction in PG-metabolizing enzymes. Administration of SC-236, a PTGS2 inhibitor, along with LPS attenuated cervical softening, consistent with the essential role of PGs in LPS-induced ripening. In contrast, during term and preterm ripening mediated by the antiprogestin, mifepristone, cervical PG levels, and expression of PG synthetic and catabolic enzymes did not change in a manner that supports a role for PGs. These findings in mice, supported by correlative studies in women, suggest PGs do not regulate all aspects of the parturition process. Additionally, it suggests a need to refocus current strategies toward developing therapies for the prevention of PTB that target early, pathway-specific processes rather than focusing on common late end point mediators of PTB.

Indexed as

AnimalsBenzenesulfonamidesCervical RipeningCervix UteriFemaleFlow CytometryGene Expression RegulationLipopolysaccharidesMiceMifepristoneMisoprostolObstetric Labor, PrematurePregnancyPregnancy, AnimalPremature BirthProgestins4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamideBenzenesulfonamidesLipopolysaccharidesMifepristoneMisoprostolProgestinsProstaglandinsPyrazolesSteroidsSulfonamides

Identifiers

PMID24189143
PMCPMC3868800
OpenAlexW2147198842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.